DeepMatter Group PLC DeepMatter Appoints Industry Advisors
16 12월 2019 - 4:01PM
RNS Non-Regulatory
TIDMDMTR
DeepMatter Group PLC
16 December 2019
DeepMatter Group plc
("DeepMatter", the "Company" or "the Group")
DeepMatter Appoints Industry Advisors
DeepMatter strengthens its depth of knowledge and industry links
in Research & Medicinal Chemistry, Process Chemistry and
Automation
16 December 2019 - DeepMatter (AIM: DMTR), the AIM-quoted
company focusing on digitising chemistry, is delighted to welcome
three leading sector figures as industry advisors on its commercial
roll-out of DigitalGlassware(TM). The advisors bring in-depth
knowledge in research & medicinal chemistry, process chemistry
and industrially focused closed-loop robotics and automation, all
target industries for DigitalGlassware(TM), the Company's
innovative cloud-based digital chemistry platform that brings
recordability, reproducibility and shareability to the lab.
The advisors will contribute to the ongoing development of the
DigitalGlassware(TM) strategic roadmap and are as follows:
-- Dr Richard Bourne - a leading academic in Process Chemistry.
Richard is Associate Professor at the University of Leeds based at
the Institute of Process Research and Development, working on rapid
process development and continuous flow chemistry. In November
2019, he was announced as a new Royal Academy of Engineering Senior
Research Fellow in Digital Manufacturing and Discovery of
Pharmaceuticals.
-- Dr John Harris - a pharmaceutical industry consultant with a
wealth of research chemistry knowledge and expertise. John was
previously Head of the Wellcome Foundation's UK cardiovascular
therapeutic area and founder of BioFocus, a highly successful
early-stage CRO, now part of the Charles River organisation.
-- Dr David M Parry - an experienced synthetic chemist, with a
track record of delivering complex projects within the pharma and
biotech sectors. David built and ran a business focused on
automated medicinal chemistry, where compounds would be
synthesised, then tested in a primary assay on the same platforms,
with the results fed back into the software to inform the next
round of automated synthesis.
Mark Warne, Chief Executive Officer of DeepMatter,
commented:
"We believe DigitalGlassware(TM) has the opportunity to sit at
the heart of the digitisation of chemistry, enabling chemists to
produce better molecules, faster and ultimately cheaper. We are
delighted to welcome Richard, John and David to the
DigitalGlassware(TM) team, each bringing valuable insight from
their three areas of specialism. Their expertise will help ensure
the platform meets and integrates the needs of these key
disciplines, assisting us in the commercial roll-out of our
innovative cloud-based digital chemistry platform."
For more information, please contact:
DeepMatter Group plc T: 0141 548 8156
Mark Warne, Chief Executive Officer
Shore Capital (Nominated Adviser and
Broker) T: 020 7408 4050
Tom Griffiths
David Coaten
Alma PR T: 020 3405 0205
Caroline Forde deepmatter@almapr.co.uk
Jessica Joynson
Kieran Breheny
About DeepMatter Group plc
DeepMatter's long term strategy is to integrate chemistry with
technology, thereby enabling a greater use of artificial
intelligence and reaching a point where chemicals can be
autonomously synthesised through robotics. In the near term this
involves the provision of an integrated software, hardware and
artificial intelligence enabled platform, DigitalGlassware(TM), to
scientists across research and process development sectors.
The DigitalGlassware(TM) platform allows chemistry experiments
to be accurately and systematically recorded, coded and entered
into a shared data cloud. The platform is designed to enable
chemists to work together effectively; sharing the details of their
experiments from anywhere and in real-time, so that work is not
needlessly duplicated, time and money wasted, and ultimately so new
discoveries may be made faster.
Visit: www.deepmatter.io and follow @deepmattergroup
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NRAMMMMZNFZGLZM
(END) Dow Jones Newswires
December 16, 2019 02:01 ET (07:01 GMT)
Cronin (LSE:CRON)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Cronin (LSE:CRON)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024